Watchlist for March 12, 2008

This morning's flat open hints at a day of consolidation. That would certainly be healthy after yesterday's huge move. But I'd still like to see some follow-through sonner rather than later. The indices breaking their 10-day moving averages would be a good start.

On Today's Calendar:

10:30 -- Crude Inventories

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates. Also be sure to check my typical swing trade entry & exit rules.

Potential day trades:

(From Briefing.com)

Gapping Down

In reaction to weak earnings/guidance: DIVX -28.4% (also downgraded to Source of Funds at ThinkEquity and downgraded to Mkt Perform at Barrington), HUM -20.8%, DECC -11.4%, AMIE -10.5%, PED -8.7%, PSS -6.3%, VIP -5.0%, CODI -4.6%, ICFI -4.5%, XOMA -3.9%, SVNT -3.0%, AKRX -2.3%, ENZ -2.3%, GLBC -2.0%, IRETS -2.0%, GPOR -1.9%, AAON -1.4%... Health insurance names showing continued weakness following HUM's (-20.8%) warning: WCG -12.1%, CVH -8.7%, HNT -7.5% (also hearing removed from Conviction Buy list at tier 1 firm), UNH -6.6%, AET -6.2%, CI -3.9%... Other news: PGNX -48.3% (update on Phase III clinical trial of intravenous methylnaltrexone for postoperative ileus, treatment did not achieve the primary end point of the study), BLUD -24.1% (to acquire BioArray Solutions; expects this acquisition to be materially dilutive to EPS for several years), CPHD -9.7% (comments on study regarding MRSA surveillance and reaffirms guidance), DPM -3.9% (announces commencement of public offering of common units), WM -1.5% (Moody's downgrades WaMu's covered bonds ratings to Aa1 and review for possible downgrade), CDNS -1.3% (acquires Chip Estimate; no terms disclosed), NVT -1.2% (EU to deepen antitrust probe into Nokia-Navteq deal, sources say - DJ)... Analyst downgrades: PKOH -9.2% (downgraded to Hold at Morgan Joseph), KLAC -5.6% (downgraded to Underperform at Oppenheimer), SEH -3.7% (downgraded to Equal Weight at First Analysis), LVLT -3.0% (downgraded to Hold at Jefferies), UAUA -2.6% (downgraded to Underweight at JPMorgan), LCC -2.1% (downgraded to Underweight at JPMorgan), NTAP -1.9% (downgraded to Neutral at Baird), AMR -1.7% (downgraded to Underweight at JPMorgan), NWA -1.6% (downgraded to Underweight at JPMorgan), DAL -1.6% (downgraded to Neutral at JPMorgan), LOW -1.4% (downgraded to Underperform at Morgan Keegan).

Gapping Up

In reaction to strong earnings/guidance: HDL +26.1%, QTWW +17.5%, TLCV +15.3%, MBLX +11.7%, JASO +9.4%, JCG +5.6% (also upgraded to outperform at Raymond James), AEO +4.1%, DXCM +3.7%, TTWO +2.6%, CAT +2.3%, EXLS +1.9%, STLD +1.6%... Select European financial names showing strength: UBS +3.6%, ING +3.3%, BCS +3.3%, CS +3.3%, DB +1.0%... Select solar names showing strength following JASO earnings: SOLF +2.1%, ESLR +1.8%, STP +1.7% (prices $500 mln convertible senior notes), SPWR +1.6%, AKNS +1.2%, CSIQ +1.1%... Other news: TWTI +40.8% (confirms HPV clinical trial achieves primary clinical endpoints), CRXX +20.9% (says drug candidate CRx-191 demonstrates 'positive' phase 2 results in psoriasis), DNDN +11.4% (FDA agrees to amend Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE), SIMO +7.9% (announces $40 mln stock repurchase program), FLDR +6.5% (announces a supply agreement with Lowe's), TASR +2.8% (announces United States Air Force Security Forces to deploy TASER X26 devices), CAM +2.7% (announces $650 mln contract for subsea equipment offshore West Africa), BHP +2.3%, RTP +2.2%, WWE +1.0% (Cramer makes positive comments on MadMoney)... Analyst upgrades: TMA +31.4% (upgraded to Peer Perform at Bear Sterns), DMND +4.1% (upgraded to Buy from Neutral at Piper Jaffray), ABH +2.3% (upgraded to Mkt Perform at BMO), DVA +1.3% (upgraded to Outperform at Piper Jaffray), NTY +1.2% (upgraded to Outperform at RBC), SSRX +1.1% (initiated with a Buy at Brean Murray).